Meloxicam Eg

Meloxicam, the active ingredient in Meloxicam Eg, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to reduce inflammation and pain in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain.

GNH USA supplies Meloxicam Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that targets inflammatory pathways in musculoskeletal disorders.

- Osteoarthritis: alleviates joint pain and improves mobility. - Rheumatoid arthritis: reduces synovial inflammation and joint damage. - Ankylosing spondylitis: diminishes spinal stiffness and pain. - Acute pain: provides rapid relief of moderate to severe pain episodes.

Meloxicam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dyspepsia: stomach discomfort or indigestion. - Nausea: feeling of queasiness. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness. - Peripheral edema: swelling of the lower limbs. - Elevated blood pressure: mild increase in systolic or diastolic pressure.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: potentially life‑threatening. - Cardiovascular events: increased risk of heart attack or stroke. - Hepatic injury: abnormal liver function tests or hepatitis. - Renal impairment: reduced kidney function or acute kidney injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rare but severe allergic reaction.

Before prescribing Meloxicam, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Gastro‑intestinal risk: assess history of ulcers or bleeding before use. - Renal function: monitor serum creatinine and electrolytes in patients with kidney disease. - Cardiovascular disease: use caution in patients with hypertension, heart failure, or prior thrombotic events. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Pregnancy and lactation: avoid use unless benefits outweigh potential risks, as safety data are limited. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Meloxicam can alter the pharmacokinetics or pharmacodynamics of several co‑administered drugs.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - ACE inhibitors or ARBs: possible reduction in renal function. - Lithium: elevated lithium serum levels. - Methotrexate: enhanced methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced renal clearance. - Antihypertensives: possible attenuation of blood‑pressure‑lowering effect. - SSRIs or SNRIs: modest increase in bleeding tendency. - Corticosteroids: additive risk of gastrointestinal ulceration. - Cyclosporine: may increase nephrotoxic potential.